Steve Pakola
Company: REGENXBIO
Job title: Chief Medical Officer
Seminars:
Chair Led Q&A: Making Strides Forward in Drug Delivery & Dosing 2:55 pm
day: Day One
Utilizing Gene Therapy to Induce Long Term Treatment of Wet AMD & DME 2:30 pm
Exploring the durability of gene therapy in providing long term treatment for Wet AMD & DME Understanding the safety issues surrounding the constant and permanent production of anti-VEGF into the back of the eye Potential treatment limitations for clinicians administering a gene therapy solution to patientsRead more
day: Day One
Panel Discussion: Ending the Burden of Monthly Treatments – Mechanisms to Increasing the Durability & Accessibility of Wet AMD & DME Therapeutics 10:45 am
Exploring extended-duration therapeutic possibilities with a focus on the anti-VEGF pathway Understanding how to increase drug durability and bring more convenient, safe drug delivery options to patients Achieving longer-term VEGF suppression through gene therapy, oral therapeutics or combination approaches with other drug modalitiesRead more
day: Day One